GlaxoSmithKline

May 2025 - Apr 2026 May 2024 - Apr 2025 May 2023 - Apr 2024 May 2022 - Apr 2023 May 2021 - Apr 2022 May 2020 - Apr 2021 May 2019 - Apr 2020 May 2018 - Apr 2019 May 2017 - Apr 2018 May 2016 - Apr 2017 May 2015 - Apr 2016 May 2014 - Apr 2015 May 2013 - Apr 2014 May 2012 - Apr 2013 May 2011 - Apr 2012 May 2010 - Apr 2011 May 2009 - Apr 2010 May 2008 - Apr 2009 May 2007 - Apr 2008 May 2006 - Apr 2007 May 2005 - Apr 2006

Lobbyists Employed

  • Cleveland, Skip
    (Details)

    498 Wentworth Lane
    Daleville, VA 24083

    540-525-3161

    Registered: 5/1/2018
    Matters: Vaccines Procurement
    Job title: Senior Acct Spec Vaccines
  • Gardner, Katherine Maeve
    (Details)

    2633 Lakeview Dr
    Raleigh, NC 27609

    919-803-4378

    Registered: 5/3/2018
    Matters: Matters pertaining to GlaxoSmithKline
    Job title: Director, State Government Affairs

Lobbyists Retained

  • Grossman, Richard K
    Firm: Vectre Corp
    (Details)

    707 E Main St
    Ste 1800
    Richmond, VA 23219

    804-644-6600

    Registered: 5/3/2018
    Firm: Vectre Corp
    Matters: Matters pertaining to GlaxoSmithKline
2019 Regular Session; 2019 Special Session I
All Issues Civil Procedure Consumer Protection Health Insurance Prescription Medicine Public Health Regulations State Budget

HB1700

49 Close Floor Votes

Budget Bill.
Chief Patron: Chris Jones
Status: Enacted

HB2223

Close Floor Vote

Pharmacies; delivery of prescription drugs, pharmacy benefits managers.
Chief Patron: Israel O'Quinn
Status: Killed

HB2515

Health plans; calculation of enrollee's contribution.
Chief Patron: Tim Hugo
Status: Enacted

HJ626

Shingles prevention; VDH to take action to increase awareness of shingles.
Chief Patron: Chris Stolle
Status: Passed

SB1100

Budget Bill.
Chief Patrons: Emmett Hanger, Tommy Norment
Status: Killed

SB1308

Prescription drugs; price gouging prohibited.
Chief Patron: John Edwards
Status: Killed

SB1596

Health plans; calculation of enrollee's contribution.
Chief Patron: Siobhan Dunnavant
Status: Enacted

SB1619

Evidence; establishes that a party or potential litigant has a duty to preserve.
Chief Patron: Mark Obenshain
Status: Enacted

Entertainment Expenses $511
Gift Expenses $0
Communication Expenses $0
Personal Expenses $2,372
Employed
Katherine Maeve Gardner
$5,990
Retained
Vectre Corp
$6,340
Honoraria Expenses $0
Total Expenses $15,213
Matters: Vaccines Procurement

Principal contact for GlaxoSmithKline:

  • James Campolongo
    209 Mallard Dr E
    North Wales, PA 19454

    215-896-9207

Information on this page comes from public documents on file with the office of the Virginia Conflict of Interest and Ethics Advisory Council.